Combined Consideration of Sex, Genotype, and Total Liver Volume Progression Determines the Risk of Hospitalization in an International Multicenter Cohort of Autosomal Dominant Polycystic Liver Disease
Dana Sierks, Jan Halbritter(Harvard University), Tabinda Jawaid(Mayo Clinic), J Degenhardt(University Hospital Cologne), Jonathan de Fallois(University of Cologne), Whitney Besse(Yale University), John A. Sayer(Newcastle upon Tyne Hospitals NHS Foundation Trust), Marie‐Pierre Audrézet(Inserm), Joost P.H. Drenth(Radboud University Nijmegen), Ria Schönauer(Charité - Universitätsmedizin Berlin), Frederik Nevens(KU Leuven), Thomas Berg(University Hospital Leipzig), Terry Watnick(University of Maryland, Baltimore), Bernhard Schlevogt(University Hospital Münster), Émilie Cornec-Le Gall(Université Européenne de Bretagne), Peter C. Harris(Mayo Clinic), Léa Caroff(Université de Bretagne Occidentale), Melissa M. Boerrigter(Radboud University Nijmegen)
Cited by 0
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698